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ABSTRACT
Objective: Transient ischaemic attack (TIA) is a
recognised risk factor for stroke in the older population
requiring timely assessment and treatment by a
specialist. The need for such TIA services is driven by
the epidemiology of transient neurological
symptoms, which may not be caused by TIA. We
report prevalence and incidence of transient
neurological symptoms in a large UK cohort study of
older people.
Design: Longitudinal cohort study
Setting: The Medical Research Council Cognitive
Function and Aging Study (CFAS) is a population
representative study based on six centres across
England and Wales.
Participants: Random samples of people in their
65th year were obtained from Family Health
Service Authority lists. The participation rate
was 80% (n=13 004). Interview at baseline included
questions about stroke and three transient
neurological symptoms, repeated in a subsample
after 2 years. Patients were flagged
for mortality.
Main outcome measures: Prevalence and 2-year
incidence of transient neurological symptoms.
Results: In 11 903 participants without a history of
stroke, 271 (2.3%) reported transient problems with
speech, 872 (7.6%) with sight and 596 (5.1%)
weakness in a limb with 1456 (12.7%) reporting at
least one symptom. Of those reinterviewed (n=6748),
675 (9.8%) reported at least one symptom over
2 years.
Conclusions: Lifetime prevalence and incidence of
transient neurological symptoms in people aged
65 years and over is high and is substantially greater
than the incidence of TIA in hospital-based and
population-based studies. These high rates of transient
neurological symptoms in the community in the older
population should be considered when planning TIA
services.
ARTICLE SUMMARY
Article focus
▪ Prompt initiation of secondary prevention follow-
ing transient ischaemic attack (TIA) is associated
with up to 80% reduction in risk of subsequent
stroke.
▪ Many people presenting to specialist TIA clinics
with transient neurological symptoms do not
have TIA.
▪ The prevalence and incidence of transient neuro-
logical symptoms (as opposed to TIA) in older
age groups is unknown.
Key messages
▪ In a large multicentred community-based study
representative of the older population in the UK,
we found a high prevalence and incidence of
transient neurological symptoms, significantly
greater than that of TIAs in hospital-based and
population-based studies.
▪ These high rates of transient neurological symp-
toms in the community in the older population
should be considered when planning TIA
services.
Strengths and limitations of this study
▪ Previous studies of incidence and prevalence of
transient neurological symptoms have mostly
been conducted in populations not representative
of older age groups where TIA is most common
and few have been undertaken in UK
populations.
▪ The incidence of transient neurological symptoms
in the study was determined in people without
severe cognitive impairment, and may be an under-
estimation, since cognitive impairment can be a
manifestation of vascular disease. The wording of
questions to identify transient neurological symp-
toms may have picked up some people who had
symptoms lasting more than 24 h.
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INTRODUCTION
Transient ischaemic attack (TIA) is an established and
powerful risk factor for stroke. Eight per cent of patients
who have TIA suffer from stroke within 7 days, many
within 48 h.1 2 Immediate specialist assessment and treat-
ment is associated with substantial reductions in this
early risk of stroke,3 and is recommended for people
with suspected TIA.4
As awareness grows of the urgency of early manage-
ment of TIA among both primary care practitioners and
the general public,5 more patients with symptoms sug-
gestive of TIA are likely to present to primary and sec-
ondary care services. Need for specialist services will be
driven by incidence of symptoms that might represent
TIA (ie, transient neurological symptoms) rather than
the epidemiology of TIA per se. Currently about 48 000
probable or deﬁnite TIAs (transient neurological symp-
toms lasting less than 24 h of likely vascular aetiology)
and 43 000 minor strokes (stroke events causing minimal
or no neurological deﬁcits) are managed as outpatients
every year in England, but it is not clear to what extent
this might be the tip of the iceberg.6 Data are available
worldwide on the prevalence and incidence of TIA.7–11
The epidemiology in the community of transient neuro-
logical symptoms (ie, neurological symptoms of sudden
onset of which TIA is a subset) is however less well
deﬁned. Previous studies of incidence and prevalence of
transient neurological symptoms have mostly been con-
ducted in populations not representative of older age
groups where TIA is most common.7 11–16 Very few have
been undertaken in UK populations. While incidence of
transient neurological symptoms will drive the need for
specialist TIA services, prevalence of transient neuro-
logical symptoms in the community is also important.
TIA is associated with a long-term increase in risk of
stroke,17 18 so there may be value in diagnosing ‘old’
events that have not presented to medical services in
order to target secondary prevention. Hence, the import-
ance of determining both the incidence and prevalence
of transient neurological symptoms in the community.
This study reports prevalence and incidence of three
common transient neurological symptoms (limb weak-
ness, loss of speech and disturbance of vision) in a
population-based multicentred cohort study in the UK
(England and Wales) in those aged 65 years and over,
the Medical Research Council Cognitive Function and
Ageing Study (CFAS).19
METHODS
The Medical Research Council CFAS is a population-
representative study of individuals aged 65 years and over.
The study began in 1991 and was designed to determine
the incidence of dementia in the older population. It has
six centres across England and Wales chosen to represent
the national variation of urban–rural mix, socioeconomic
deprivation and rates of chronic disease.19 Five of these
with identical study designs (Oxford, Nottingham,
Cambridgeshire, Gwynedd and Newcastle) are used in
the present investigation. The sixth centre (Liverpool)
used a different design and is therefore excluded.
Random samples of people in their 65th year and above
were obtained from Family Health Service Authority lists
(agency responsible for maintaining registers of general
practice populations at that time). The sample was strati-
ﬁed by age (65–74, 75 years and over) and equal
numbers were randomly selected from these groups with
the aim of recruiting 2500 to each centre. All study
centres obtained ethical approval from local research
committees (REC Ref: 05/MRE05/37). Full details of
methodology are available elsewhere.19
Eligible participants (or their proxies where appropri-
ate) provided informed consent. Trained interviewers
undertook baseline interviews in the participants’
homes, including sociodemographic characteristics, cog-
nitive function and disease history, including previous
stroke, coronary heart disease and diabetes (full details
at http://www.cfas.ac.uk). On the basis of baseline
screening, the study sample was divided into two groups
at baseline: people without cognitive impairment and a
group consisting of those with cognitive impairment
plus a stratiﬁed subsample of those without cognitive
impairment. The ﬁrst group underwent no further
assessment at baseline and was ‘rescreened’ after 2 years.
The second group underwent a further detailed cogni-
tive assessment at baseline, but was not followed up for
transient neurological symptoms. The estimates of preva-
lence of transient neurological symptoms are calculated
for all people at baseline, while the incidence estimates
use only the ﬁrst group. All participants were ﬂagged
with the National Health Service (NHS) Central
Register. Deaths and underlying causes of death attribu-
ted to stroke (International Classiﬁcation of Diseases
(ICD) codes 430–438) were notiﬁed to the study.
Prevalence of transient neurological symptoms
At baseline all participants were asked “Have you ever
experienced sudden problems with:
1. speech, which got better after a day?
2. weakness in the arms or legs, which got better after a
day?
3. sight, which got better after a day?”
Social class was determined using the Registrar
General’s Occupational Classiﬁcation. Cognitive status
was determined using the Mini-Mental State Examination
(MMSE)20 and the Automated Geriatric Examination for
Computer Assisted Taxonomy (AGECAT).21
Incidence of transient neurological symptoms
All those in the ‘rescreen’ arm were asked at 2-year
follow-up if they had experienced each transient neuro-
logical symptom in the past 2 years.
ANALYSIS
All analyses were carried out using STATA V.11. Inverse
probability weights were used throughout to ensure that
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the sample was representative of the target population.
Weights were estimated with logistic regression using
presence in each phase of the study as an outcome and
taking into account oversampling of over-75s at baseline.
Weights for incidence calculations adjust for attrition
based on baseline characteristics and stratiﬁed selection
into the assessment arm as appropriate. Baseline preva-
lence of each transient neurological symptom was calcu-
lated for age-speciﬁc strata and as a weighted percentage
to provide a population estimate of prevalence for
people aged 65 years and over. Associations with gender,
age, social class (manual (IIIb, IV and V) and non-
manual (I, II and IIIa)) and cardiovascular comorbidity
were explored using logistic regression models adjusting
for all other factors and cognitive function based on
MMSE by score (less than 18, 18–21, 22–25 and 26–30).
Two-year incidence of transient neurological symp-
toms was estimated using weighted percentages of those
reporting any of the symptoms during follow-up.
Weights were adjusted for refusals, dropouts and for
non-reassessment of people with cognitive impairment.
Calculation of attrition weights for incident transient
neurological symptoms excluded those who died
between baseline and follow-up. These estimates are
therefore applicable to the population over 65 years
without severe cognitive impairment or stroke at base-
line surviving at least 2 years.
RESULTS
The participation rate in the CFAS was 80% (13 004/
16 258). For the prevalence analysis, participants who
had a stroke at baseline (963, 7.4%) or for whom base-
line information about stroke was missing (138, 1.1%)
were excluded, leaving 11 903 participants. In total, 2283
of the original participants were not allocated to the
‘rescreen’ arm at 2 years; 754 died, 1973 declined to par-
ticipate and 145 were lost to follow-up, leaving 6748
(76% response rate of potential participants) for the
incidence analysis.
Table 1 shows the demographic features of partici-
pants in the CFAS, studied in this analysis at baseline.
Forty per cent of participants were men and 60% were
women. 12.3% of all participants reported at least one
transient neurological symptom; 2.3% reported transient
loss of speech, 5.1% transient weakness and 7.6% transi-
ent loss of sight.
Table 2 shows prevalence data with weighted percen-
tages and ORs (adjusted for age, sex, social class, cogni-
tion and cardiovascular morbidities) of reported
transient neurological symptoms at baseline by demo-
graphic factors and comorbidities. In total, 12.8% of
men and 12% of women reported at least one of the
three transient neurological symptoms of loss of speech,
loss of sight or weakness. There was no signiﬁcant associ-
ation of gender with reporting at least one transient
neurological symptom, but signiﬁcantly lower odds of
reporting a transient neurological symptom in the over
85 age group. The odds of reporting any transient
neurological symptom were higher in those in manual
compared to non-manual social classes. The presence of
cardiovascular morbidities of angina and heart attack
were also signiﬁcantly associated with the odds of having
at least one of the transient neurological symptoms.
There was no difference between genders with regard
to reporting individual transient neurological symptoms
of loss of speech, loss of sight or weakness. However,
there was a signiﬁcantly lower odds of reporting transi-
ent visual loss in those aged over 85 years, and an
increased odds of reporting transient symptoms of weak-
ness and loss of sight in manual compared to non-
manual social classes. The presence of cardiovascular
comorbidities of angina and heart attack were associated
with higher odds of all three symptoms.
Table 3 shows 2-year incidence of transient neuro-
logical symptoms in respondents attending the
‘rescreen’. A total of 9.8% of participants reported at
least one transient neurological symptom over the past
2 years, with the highest incidence of reported transient
neurological symptoms being due to loss of sight fol-
lowed by weakness, with loss of speech being the least
frequently reported transient neurological symptom.
The incidence of each of the transient neurological
symptoms was highest in the 75–84 age group and lowest
in the over 85 age group.
DISCUSSION
Our ﬁndings suggest that transient neurological symp-
toms are common in the older population in England
Table 1 Demographics of participants in the Cognitive
Function and Aging Study (CFAS) by sex, age, social
class and comorbidity (data are counted in percentages)
All (n=11903)
Males
(n=4689)
Females
(n=7214)
N
Per
cent* N
Per
cent* N
Per
cent*
Age (years)
65–74 5980 58.8 2635 64.5 3345 55.0
75–84 4624 32.1 1716 29.6 2908 33.8
85+ 1299 9.1 338 5.9 961 11.2
Social class
I 558 4.8 225 4.8 333 4.8
II 2988 26.1 1213 26.3 1775 25.9
IIIa 1337 11.6 456 9.9 881 12.8
IIIb 4295 37.7 1865 40.8 2430 35.5
IV 1727 14.9 650 13.9 1077 15.7
V 561 4.9 196 4.3 365 5.3
Comorbidity
Angina 1923 16.3 878 15.3 1045 11.1
Diabetes 672 5.5 310 6.4 362 4.9
Heart
attack
1139 9.5 632 13.6 507 6.8
*Weighted percentages.
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Table 2 Distribution and adjusted odds of transient neurological symptoms in those aged 65 years or over in the Cognitive Function and Aging Study (CFAS) by sex,
social class and comorbidity (data are counted in percentages)
Loss of speech Weakness Loss of sight At least one symptom
N Per cent* OR† (95% CI) N Per cent* OR† (95% CI) N Per cent* OR† (95% CI) N Per cent* OR† (95% CI)
Gender
Male 119 2.5 1.0 257 5.5 1.0 347 7.6 1.0 598 12.8 1.0
Female 152 2.2 0.9 (0.7 to 1.2) 339 4.8 0.9 (0.7 to 1.0) 525 7.6 1.0 (0.9 to 1.2) 858 12.0 1.0 (0.9 to 1.1)
Age (years)
65–74 137 2.3 1.0 302 5.1 1.0 480 8.1 1.0 768 12.9 1.0
75–84 104 2.3 0.7 (0.7 to 1.2) 229 5.0 0.9 (0.7 to 1.1) 327 7.2 0.9 (0.7 to 1.1) 553 12.0 0.9 (0.8 to 1.0)
85+ 30 2.5 0.8 (0.5 to 1.3) 65 5.4 0.9 (0.6 to 1.2) 65 5.4 0.6 (0.5 to 0.8) 134 10.4 0.7 (0.6 to 0.9)
Social class‡
Non-manual 96 5.8 1.0 63 11.0 1.0 295 17.9 1.0 497 10.2 1.0
Manual 164 7.2 1.1 (0.9 to 1.5) 390 17.8 1.4 (1.2 to 1.7) 556 25.7 1.4 (1.2 to 1.6) 920 14.1 1.4 (1.2 to 1.6)
Comorbidity
Angina (n=1538) 64 4.3 1.5 (1.0 to 2.2) 176 11.7 2.5 (2.0 to 3.2) 160 10.6 1.3 (1.0 to 1.6) 312 20.7 1.7 (1.4 to 1.9)
Diabetes (n=672) 28 4.0 1.4 (0.9 to 2.2) 40 6.1 1.0 (0.7 to 1.4) 66 10.1 1.3 (0.9 to 1.7) 102 15.2 1.1 (0.9 to 1.4)
Heart attack (n=1139) 52 4.7 1.8 (1.2 to 2.7) 131 10.5 1.4 (1.2 to 1.9) 119 11.5 1.4 (1.1 to 1.8) 233 12.4 1.4 (1.2 to 1.8)
*Weighted percentages.
†Adjusted for age, sex, social class, cognition and cardiovascular comorbidities.
‡Reference non-manual (I, II and IIIa) compared to manual social class (IIIb, IV and V).
156 participants had missing data on the speech questionnaire, 155 on the weakness and 154 on the sight question.
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and Wales, with at least 12% of people aged 65 years
and over having experienced a transient neurological
symptom of the arm or leg, speech or vision, which gets
better after a day, and approximately 5% having experi-
enced at least one such symptom over the course of a
year. The commonest of these was transient symptoms of
vision, followed by limb weakness. Those aged over
85 years reported lower rates of transient neurological
symptoms, predominantly due to less frequent reporting
of transient visual loss. Problems of memory and recall
may have contributed to under-reporting, and higher
mortality rates associated with neurological incidents to
underestimation of rates of transient neurological symp-
toms in this age group. Chronic visual problems may
have also potentially masked transient visual losses in the
oldest-old population. Incidence of at least one transient
neurological symptom in the CFAS population was
approximately 2.6 times greater than that of conﬁrmed
TIA presenting to medical services in the Oxford
Vascular (OxVASC) study in people aged over 85 years
(approximately 15/1000/year), eight times greater in
those aged 75–84 years (7/1000/year) and approxi-
mately 15 times greater in those aged 65–74 years (3/
1000 population/year).10
The prevalence and incidence of transient neuro-
logical symptoms in the CFAS was somewhat higher than
those found by questionnaires used in other studies
internationally (mostly conducted in younger age
groups), but comparable to those of Wilkinson et al in
an over 60 age group in a US-based study.7 12–14 16
Online supplementary table S4 shows the prevalence of
sudden onset of neurological symptoms of weakness in a
limb or of loss of speech or sight in previous population
and community studies.7 12–14 16 Questions used to elicit
transient neurological symptoms in the CFAS are likely
to have captured greater numbers of transient neuro-
logical events in the population compared with those
seeking more speciﬁc vascular symptoms, or to the few
studies deﬁning more precisely the onset, offset and
timing of the event.7 12–14 While some respondents will
have been describing true transient ischaemic events, it
is likely that many did not have a true TIA. Validated
measures to determine the presence of previous TIA are
limited, and most studies of transient neurological
symptoms in questionnaires overestimate true transient
ischaemic attacks.13 14 22 Wilkinson et al14 suggest that
around 10% of transient symptoms reported in a ques-
tionnaire are subsequently diagnosed as TIA after a
neurologist’s assessment. Self-reported transient neuro-
logical symptoms in other community-based studies have
low positive predictive value, with higher values only in
studies in outpatient populations (over 70%).13 14 22–24
This suggests that the use of screening to identify pos-
sible past transient ischaemic attacks may generate
unnecessary extra strain on primary care and secondary
TIA services with limited beneﬁt.
Patients presenting with transient neurological symp-
toms present considerable diagnostic dilemmas for
primary care practitioners reﬂected in low rates of TIA
diagnosis conﬁrmation in patients referred to UK TIA
clinics (over 50% being for non-TIA causes).6 25 26 Many
symptoms of TIA are non-speciﬁc and occur in non-
vascular syndromes. Dizziness, ophthalmological pro-
blems, migraine, epilepsy, nerve entrapment or psycho-
logical states are the commonest non-TIA diagnoses.25–29
Often, however, no diagnosis can be determined.25 26
Scales such as the ABCD22 help determine the urgency
of TIA referral, but do not distinguish TIA from non-TIA
symptoms. Wilkinson et al14 reported transient loss of
speech and loss of sight to be more reliable than limb
weakness for neurologist diagnosis of TIA, while Hart
et al7 found the strongest and most consistent relationship
with subsequent stroke to be loss of power in an arm.
Other studies suggest that the presence of certain symp-
toms such as headache, dizziness, loss of consciousness,
memory loss, blurred vision, generalised weakness, pain
in limbs and seizures make the diagnosis of TIA less
likely.14 29 30
Study limitations
The incidence of transient neurological symptoms was
determined in people without severe cognitive impair-
ment, and may be an underestimate since cognitive
impairment can be a manifestation of vascular disease.31 32
Only three transient neurological symptoms were
reported in this study. Some symptoms of TIA (eg, poster-
ior circulation or pure sensory symptoms) were not
sought. The wording of questions to identify transient
Table 3 Two-year incidence of transient neurological symptoms in the Cognitive Function and Aging Study (CFAS) in those
without stroke at baseline at 2-year screening assessment, N at 2 years was 6748 (data are in N (%))
Transient neurological symptoms
Age (years)
All 65–74 (N=3657) 75–84 (N=2618) 85+ (N=473)
N Per cent* N Per cent* N Per cent* N Per cent*
Loss of speech 149 2.1 55 1.5 84 3.3 10 2.0
Weakness 239 3.7 117 3.4 106 4.1 16 3.4
Loss of sight 410 6.3 214 6.3 170 6.6 26 4.5
At least one symptom 675 9.8 327 9.3 304 11.6 44 7.8
*Weighted percentage.
98 participants had missing data on the speech questionnaire, 97 on the weakness and 105 on the sight question.
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neurological symptoms may have picked up some people
who had symptoms lasting more than 24 h. Such patients
are nevertheless likely to draw on TIA services for further
assessment. In addition, it was not possible to determine
whether different transient neurological symptoms in a
participant occurred simultaneously or separately in
time. The problem of recall bias in these self-reports of
transient symptoms needs to be considered. Questions
were designed to be easily comprehensible to the older
population. However, the need to consider multiple cri-
teria when responding to a question, for example,
‘sudden onset’ and ‘less than a day’, may have led to difﬁ-
culties in interpretation of the transient neurological
symptoms questions for some participants. Finally, base-
line and 2-year follow-up were carried out in the 1990s
and changes in the rates of vascular events may have
occurred since then. While the age-speciﬁc incidence of
stroke appears to be declining, it is not clear that the
same is true of TIA.10 33 34 This study is more recent than
many studies estimating rates of transient neurological
symptoms in the population, many of which have been
carried out during the 1970s or 1980s.12–14
CONCLUSION
In a large multicentred community-based study, highly
representative of the older population in the UK and
conducted in the age group where TIAs are most
common, we found a high prevalence and incidence of
transient neurological symptoms. The incidence of such
symptoms in the community is signiﬁcantly greater than
that of TIAs. This highlights the need for adequate provi-
sion of TIA services and the potential importance of the
development of valid diagnostic tools to assist the general
practitioner and hospital doctor in better triage of
people presenting with transient neurological symptoms.
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